THROMBO INCODE
DEAD

Serial Number

90389413

Owner

GENINCODE U.K., LTD.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Dec 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

THROMBO INCODE Trademark

Serial Number: 90389413

THROMBO INCODE is a trademark filed by GENINCODE U.K., LTD. on December 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

GENINCODE U.K., LTD. (5 trademarks)

One St. Peters Square

Entity Type: 99

Trademark Details

Filing Date

December 17, 2020

Registration Date

Not Registered

Published for Opposition

July 12, 2022

Goods & Services

medical diagnostic reagents; genetic identity tests comprised of reagents for medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease risk assessment, namely, thrombotic diseases and other related coagulation or anti-coagulation based diseases

medical services; diagnostic services, including testing, consulting services and reporting in the fields of medical diagnostics and disease risk assessment; genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; providing disease profiles and medical data analysis and risk assessments via an online digital portal designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; consultation in the field of health risk assessment, namely, health counseling, genetic counseling

scientific services and research, namely, medical and scientific research in the field of thrombosis, thrombotic risks and diagnosis, scientific research and development, information on the subject of scientific research in the field of biotechnology, medical and scientific research, namely, conducting clinical trials, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, providing reagent sample testing and diagnostic services for others in the field of science; genetic testing for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 10, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 10, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2022 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Dec 3, 2021 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Dec 3, 2021 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Dec 3, 2021 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Dec 3, 2021 CPEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 19, 2021 GPRN
PRIORITY ACTION E-MAILED
Jun 19, 2021 GPRA
PRIORITY ACTION WRITTEN
Jun 19, 2021 CPRA
ASSIGNED TO EXAMINER
Jun 11, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2021 NWOS
NEW APPLICATION ENTERED
Dec 21, 2020 NWAP